Michael Barbella, Managing Editor09.06.22
The world's interlaminar device market is set to grow roughly 5% annually over the next decade, thanks to an increasing global prevalence of spinal disorders, chronic back pain, and rising rates of road accidents or road traffic injuries, a Research Nester report concludes. According to the World Health Organization (WHO), approximately 1.3 million people are killed annually in traffic accidents worldwide. Between 20 and 50 million people suffer non-fatal injuries, with many incurring a disability as a result of their injury. Other interlaminar device market growth drivers include an increasing prevalence of diabetes mellitus, severe infections that damages the spinal cord such as spinal epidural abscess and meningitis, and sports injuries.
WHO estimates that between 250,000 and 500,000 people suffer from spinal cord injury every year. Moreover, according to the Centers for Disease Control and Prevention (CDC), more than 1.2 million cases of bacterial meningitis, an infection that damages the spinal cord, are estimated to occur worldwide each year.
Spinal injuries are common among athletes, and these types of injuries will help drive the interlaminar market iforward as more youngsters participate in sports as a career or hobby. Approximately 9% of all new cases of spinal cord injuries in the United States are related to sports activities. Those activities with have the highest risk of catastrophic spinal injuries are football, ice hockey, wrestling, diving, skiing, snowboarding, rugby, and cheerleading. Furthermore, technological advancements in the field of spinal surgery, increased health expenditure, and improved healthcare infrastructure worldwide is also anticipated to boost the market's growth. WHO claims global health spending rose to $8 trillion between 2000 and 2018, which is almost a 10% of the global GDP (gross domestic produt). Increasing demand for minimally invasive spine surgeries or stabilization surgeries, and the extensive use of interlaminar devices in such surgeries also will contribute to the market's expansion through 2031. Interlaminar devices give patients long lasting relief, better mobility at treatment level, and also shorten operating time and patient’s stay at hospital. Such factors are projected to boost the market's growth during the forecast period.
Regionally, the global interlaminar device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share due to the increasing number of spinal cord injuries and chronic back pain (owing to the rise in popularity of sports) across the region. For instance, sports and exercise was recorded as a part of daily routine of around 19% of the U.S. population in 2019. Moreover, approximately 450,000 people are living with a spinal cord injury, and around 17,000 new spinal cord injuries occur every year in the Unites States. Furthermore, increasing demand for minimally invasive treatments, continuous improvement and innovation in healthcare sector, and increase in healthcare expenditure, is anticipated to drive the market growth in the region. According to the American Medical Association, the U.S. healthcare expenditure rose by approximately 9% in 2020. The estimated health expenditure was around 19% of GDP in 2020, up from 17% in 2019. The Centers for Medicare & Medicaid Services estimates that U.S. healthcare expenditures rose to nearly $4 trillion.
The European market is expected to hold the second largest share of the global marke, owing to the presence of major medical device manufacturers, improving healthcare infrastructure, and implementation of new health related projects. For instance, approximately 14,000 health-related projects were implemented between 2004 and 2020 in Poland. Further, the rise in degenerative spine diseases, advancement in medical technology, and rising demand for minimally invasive treatments are projected to boost Europe's market through 2031. Along with it, growing incidence of diabetes across the region is also anticipated to drive the market's future growth. Diabetic people are at increased risk of developing spinal epidural abscess. Approximately 33% of patients with spinal epidural abscess are living with diabetes mellitus. Moreover, approximately 60 million people in Europe have diabetes, and it is estimated that number will increase to 66 million in the next eight to 10 years.
The global interlaminar device market is segmented on the basis of end user into hospitals, clinics, ambulatory surgical centers, and skilled nursing facilities, out of which, hospitals segment is anticipated to hold a significant share among all other sub-segments during the forecast period. This can be attributed to the rise in the hospitals development worldwide owing to the growing number of patients. Nearly 15,000 healthcare construction projects were in progress in the United States in 2017. Furthermore, there is growing demand for advanced medical equipment in hospitals, increased focus on improving patients’ experience at hospitals, and high hospital expenditures worldwide. About $1 trillion or above is spent on U.S. hospital care every year.
Moreover, on the basis of surgery type, the market is divided into open surgery, and minimally invasive surgery, out of which, minimally invasive surgery segment is predicted to garner the largest share over the forecast period, thanks to less operating time, less pain, smaller incision, lower mortality, and less damage to a patient’s body. According to a study by National Library of Medicine (NLM), around 208,300 patients underwent a surgical procedure, either by the open surgery or the minimally invasive surgery (MIS) approach. The MIS approach showed significantly lesser mortality, reduced sickness, lesser ICU admissions, shorter hospital stay, quicker recovery, and lesser total hospital costs. A noninvasive surgical method is also extensively used for other general procedures such as cancer and urologic surgery.
Some prominent players in the interlaminar market include NuVasive Inc., Zimmer Biomet Holdings Inc., Life Spine Inc, Xtant Medical Holdings, Alphatec Holdings Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services Inc., and Meditech Spine LLC.
WHO estimates that between 250,000 and 500,000 people suffer from spinal cord injury every year. Moreover, according to the Centers for Disease Control and Prevention (CDC), more than 1.2 million cases of bacterial meningitis, an infection that damages the spinal cord, are estimated to occur worldwide each year.
Spinal injuries are common among athletes, and these types of injuries will help drive the interlaminar market iforward as more youngsters participate in sports as a career or hobby. Approximately 9% of all new cases of spinal cord injuries in the United States are related to sports activities. Those activities with have the highest risk of catastrophic spinal injuries are football, ice hockey, wrestling, diving, skiing, snowboarding, rugby, and cheerleading. Furthermore, technological advancements in the field of spinal surgery, increased health expenditure, and improved healthcare infrastructure worldwide is also anticipated to boost the market's growth. WHO claims global health spending rose to $8 trillion between 2000 and 2018, which is almost a 10% of the global GDP (gross domestic produt). Increasing demand for minimally invasive spine surgeries or stabilization surgeries, and the extensive use of interlaminar devices in such surgeries also will contribute to the market's expansion through 2031. Interlaminar devices give patients long lasting relief, better mobility at treatment level, and also shorten operating time and patient’s stay at hospital. Such factors are projected to boost the market's growth during the forecast period.
Regionally, the global interlaminar device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share due to the increasing number of spinal cord injuries and chronic back pain (owing to the rise in popularity of sports) across the region. For instance, sports and exercise was recorded as a part of daily routine of around 19% of the U.S. population in 2019. Moreover, approximately 450,000 people are living with a spinal cord injury, and around 17,000 new spinal cord injuries occur every year in the Unites States. Furthermore, increasing demand for minimally invasive treatments, continuous improvement and innovation in healthcare sector, and increase in healthcare expenditure, is anticipated to drive the market growth in the region. According to the American Medical Association, the U.S. healthcare expenditure rose by approximately 9% in 2020. The estimated health expenditure was around 19% of GDP in 2020, up from 17% in 2019. The Centers for Medicare & Medicaid Services estimates that U.S. healthcare expenditures rose to nearly $4 trillion.
The European market is expected to hold the second largest share of the global marke, owing to the presence of major medical device manufacturers, improving healthcare infrastructure, and implementation of new health related projects. For instance, approximately 14,000 health-related projects were implemented between 2004 and 2020 in Poland. Further, the rise in degenerative spine diseases, advancement in medical technology, and rising demand for minimally invasive treatments are projected to boost Europe's market through 2031. Along with it, growing incidence of diabetes across the region is also anticipated to drive the market's future growth. Diabetic people are at increased risk of developing spinal epidural abscess. Approximately 33% of patients with spinal epidural abscess are living with diabetes mellitus. Moreover, approximately 60 million people in Europe have diabetes, and it is estimated that number will increase to 66 million in the next eight to 10 years.
The global interlaminar device market is segmented on the basis of end user into hospitals, clinics, ambulatory surgical centers, and skilled nursing facilities, out of which, hospitals segment is anticipated to hold a significant share among all other sub-segments during the forecast period. This can be attributed to the rise in the hospitals development worldwide owing to the growing number of patients. Nearly 15,000 healthcare construction projects were in progress in the United States in 2017. Furthermore, there is growing demand for advanced medical equipment in hospitals, increased focus on improving patients’ experience at hospitals, and high hospital expenditures worldwide. About $1 trillion or above is spent on U.S. hospital care every year.
Moreover, on the basis of surgery type, the market is divided into open surgery, and minimally invasive surgery, out of which, minimally invasive surgery segment is predicted to garner the largest share over the forecast period, thanks to less operating time, less pain, smaller incision, lower mortality, and less damage to a patient’s body. According to a study by National Library of Medicine (NLM), around 208,300 patients underwent a surgical procedure, either by the open surgery or the minimally invasive surgery (MIS) approach. The MIS approach showed significantly lesser mortality, reduced sickness, lesser ICU admissions, shorter hospital stay, quicker recovery, and lesser total hospital costs. A noninvasive surgical method is also extensively used for other general procedures such as cancer and urologic surgery.
Some prominent players in the interlaminar market include NuVasive Inc., Zimmer Biomet Holdings Inc., Life Spine Inc, Xtant Medical Holdings, Alphatec Holdings Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services Inc., and Meditech Spine LLC.